Finally, genetic ablation of TNF in distinct cellular sources in this colitis model revealed that soluble TNF produced by IECs controls IL-22BP expression in the colon, while transmembrane T cell-derived TNF regulated inflammation and TNF production by IECs and, thereby, Il-22 bioactivity. Here, IL22 is linked to colitis.